These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 30056126)

  • 1. Targeting the TREK-1 potassium channel via riluzole to eliminate the neuropathic and depressive-like effects of oxaliplatin.
    Poupon L; Lamoine S; Pereira V; Barriere DA; Lolignier S; Giraudet F; Aissouni Y; Meleine M; Prival L; Richard D; Kerckhove N; Authier N; Balayssac D; Eschalier A; Lazdunski M; Busserolles J
    Neuropharmacology; 2018 Sep; 140():43-61. PubMed ID: 30056126
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The TREK-1 potassium channel is involved in both the analgesic and anti-proliferative effects of riluzole in bone cancer pain.
    Delanne-Cuménal M; Lamoine S; Meleine M; Aissouni Y; Prival L; Fereyrolles M; Barbier J; Cercy C; Boudieu L; Schopp J; Lazdunski M; Eschalier A; Lolignier S; Busserolles J
    Biomed Pharmacother; 2024 Jul; 176():116887. PubMed ID: 38852511
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness assessment of riluzole in the prevention of oxaliplatin-induced peripheral neuropathy: RILUZOX-01: protocol of a randomised, parallel, controlled, double-blind and multicentre study by the UNICANCER-AFSOS Supportive Care intergroup.
    Kerckhove N; Busserolles J; Stanbury T; Pereira B; Plence V; Bonnetain F; Krakowski I; Eschalier A; Pezet D; Balayssac D
    BMJ Open; 2019 Jun; 9(6):e027770. PubMed ID: 31182448
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early Stimulation of TREK Channel Transcription and Activity Induced by Oxaliplatin-Dependent Cytosolic Acidification.
    Dionisi M; Ruffinatti FA; Riva B; Lim D; Canta A; Meregalli C; Fumagalli G; Monza L; Ferrer-Montiel A; Fernandez-Carvajal A; Cavaletti G; Genazzani AA; Distasi C
    Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 32998392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of TREK currents by riluzole in three subgroups of cultured mouse nodose ganglion neurons.
    Fernández-Fernández D; Cadaveira-Mosquera A; Rueda-Ruzafa L; Herrera-Pérez S; Veale EL; Reboreda A; Mathie A; Lamas JA
    PLoS One; 2018; 13(6):e0199282. PubMed ID: 29928032
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of the TREK2 potassium channel in cold and warm thermosensation and in pain perception.
    Pereira V; Busserolles J; Christin M; Devilliers M; Poupon L; Legha W; Alloui A; Aissouni Y; Bourinet E; Lesage F; Eschalier A; Lazdunski M; Noël J
    Pain; 2014 Dec; 155(12):2534-2544. PubMed ID: 25239074
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Topiramate prevents oxaliplatin-related axonal hyperexcitability and oxaliplatin induced peripheral neurotoxicity.
    Alberti P; Canta A; Chiorazzi A; Fumagalli G; Meregalli C; Monza L; Pozzi E; Ballarini E; Rodriguez-Menendez V; Oggioni N; Sancini G; Marmiroli P; Cavaletti G
    Neuropharmacology; 2020 Mar; 164():107905. PubMed ID: 31811874
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Class I HDAC Inhibitor, MS-275, Prevents Oxaliplatin-Induced Chronic Neuropathy and Potentiates Its Antiproliferative Activity in Mice.
    Lamoine S; Cumenal M; Barriere DA; Pereira V; Fereyrolles M; Prival L; Barbier J; Boudieu L; Brasset E; Bertin B; Renaud Y; Miot-Noirault E; Civiale MA; Balayssac D; Aissouni Y; Eschalier A; Busserolles J
    Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Riluzole prevents oxaliplatin-induced cold allodynia via inhibition of overexpression of transient receptor potential melastatin 8 in rats.
    Yamamoto S; Egashira N; Tsuda M; Masuda S
    J Pharmacol Sci; 2018 Nov; 138(3):214-217. PubMed ID: 30409714
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epigenetics Involvement in Oxaliplatin-Induced Potassium Channel Transcriptional Downregulation and Hypersensitivity.
    Pereira V; Lamoine S; Cuménal M; Lolignier S; Aissouni Y; Pizzoccaro A; Prival L; Balayssac D; Eschalier A; Bourinet E; Busserolles J
    Mol Neurobiol; 2021 Jul; 58(7):3575-3587. PubMed ID: 33772465
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neu-horizons: neuroprotection and therapeutic use of riluzole for the prevention of oxaliplatin-induced neuropathy-a randomised controlled trial.
    Trinh T; Park SB; Murray J; Pickering H; Lin CS; Martin A; Friedlander M; Kiernan MC; Goldstein D; Krishnan AV
    Support Care Cancer; 2021 Feb; 29(2):1103-1110. PubMed ID: 32607598
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alpha-linolenic acid and riluzole treatment confer cerebral protection and improve survival after focal brain ischemia.
    Heurteaux C; Laigle C; Blondeau N; Jarretou G; Lazdunski M
    Neuroscience; 2006; 137(1):241-51. PubMed ID: 16289892
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A human TREK-1/HEK cell line: a highly efficient screening tool for drug development in neurological diseases.
    Moha ou Maati H; Peyronnet R; Devader C; Veyssiere J; Labbal F; Gandin C; Mazella J; Heurteaux C; Borsotto M
    PLoS One; 2011; 6(10):e25602. PubMed ID: 22022421
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The neuroprotective agent riluzole activates the two P domain K(+) channels TREK-1 and TRAAK.
    Duprat F; Lesage F; Patel AJ; Fink M; Romey G; Lazdunski M
    Mol Pharmacol; 2000 May; 57(5):906-12. PubMed ID: 10779373
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is quantitative sensory testing helpful in the management of oxaliplatin neuropathy? a two-year clinical study.
    Delmotte JB; Beaussier H; Auzeil N; Massicot F; Laprévote O; Raymond E; Coudoré F
    Cancer Treat Res Commun; 2018; 17():31-36. PubMed ID: 30343217
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of hERG1 ion channels in epithelial-mesenchymal transition and the capacity of riluzole to reduce cisplatin resistance in colorectal cancer cells.
    Fortunato A
    Cell Oncol (Dordr); 2017 Aug; 40(4):367-378. PubMed ID: 28593575
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of temperature-sensitive leak K
    Viatchenko-Karpinski V; Ling J; Gu JG
    Mol Brain; 2018 Jul; 11(1):40. PubMed ID: 29980241
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Recent advances in the study of arachidonic acid-sensitive and mechano-gated tandem-pore-domain potassium channels--TREK].
    Li ZB; Wang XL
    Yao Xue Xue Bao; 2006 Mar; 41(3):193-6. PubMed ID: 16758986
    [No Abstract]   [Full Text] [Related]  

  • 19. Spadin, a sortilin-derived peptide, targeting rodent TREK-1 channels: a new concept in the antidepressant drug design.
    Mazella J; Pétrault O; Lucas G; Deval E; Béraud-Dufour S; Gandin C; El-Yacoubi M; Widmann C; Guyon A; Chevet E; Taouji S; Conductier G; Corinus A; Coppola T; Gobbi G; Nahon JL; Heurteaux C; Borsotto M
    PLoS Biol; 2010 Apr; 8(4):e1000355. PubMed ID: 20405001
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute changes in nerve excitability following oxaliplatin treatment in mice.
    Makker PGS; White D; Lees JG; Parmar J; Goldstein D; Park SB; Howells J; Moalem-Taylor G
    J Neurophysiol; 2020 Jul; 124(1):232-244. PubMed ID: 32519566
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.